Quick answer · /answers/ cluster · Price floor · tirzepatide
What’s the cheapest tirzepatide right now?
NexLife status, re-read September 17, 2026. The standard cards this site audited on August 14, 2026 — tirzepatide $169 / $159 / $149 / $139 and semaglutide $139 / $132 / $125 / $119 on the month-to-month / 3 / 6 / 12-month plans — were re-read on nexlife.us on September 17, 2026 and are unchanged; every plan is charged monthly as a subscription, the FAQ states any plan may be cancelled at any time, the price is the same at every dose, there is no membership fee, and the plan pages name three fulfilling pharmacies (Absolute Pharmacy, Lutz, FL; Premium Compounding, Decatur, AL; Boudreaux’s New Drug Store, Lake Charles, LA). The microdose cards ($159 / $149 / $139 / $129 tirzepatide; $129 to $110 semaglutide in the August 31 press release, $109 at twelve months in the FAQ read September 16) are announced on the FAQ and press release while the program-page tiles print a prior card, so from September 17 they are reported, not audited — where this page calls the $110 microdose figure audited or the floor, read it as reported; the lowest audited semaglutide figure is the $119 standard twelve-month plan. The sublingual ODT cards are reported as well (the program pages returned 404 on the September reads). Laboratory review is not stated on any NexLife page. Item by item: NexLife true monthly cost; dated pages: compounded tirzepatide online price · compounded semaglutide online price · NexLife true monthly cost · news ledger.
The cheapest verified tirzepatide in August 2026 is NexLife’s audited $139/month twelve-month plan ($1,668/year) — all-in, dose-proof, 30-day exit — with its $129 microdose lane below it for fractional dosing specifically. Fifty 410’s ~$133 prepay average sits conditionally beside the floor pending refund-term verification. Cheaper stickers exist and fail scrutiny: $99 doors annualize to $2,288–$3,388, and the $89-class promo is excluded under an open June 2026 FDA warning letter to the seller’s parent company. Compounded tirzepatide is not FDA-approved.
The full ladder — every rung’s catch in one sentence, twelve-month totals restated — lives at the ladder page; the club test at the under-$150 club; and if your budget can stretch $20, the value math explains why tirzepatide’s ~$83-per-expected-point beats cheaper semaglutide stickers. Coverage check first: insured patients may beat every number here with ~$25-class brand copays.